YU56302A - Derivati 8,8a-dihidro-indeno/1,2-d/taizola, koji su supstituisani u 8a-položaju,postupak za njihovu proizvodnju i njihova primena kod leka npr.kao anorektičnog sredstva - Google Patents

Derivati 8,8a-dihidro-indeno/1,2-d/taizola, koji su supstituisani u 8a-položaju,postupak za njihovu proizvodnju i njihova primena kod leka npr.kao anorektičnog sredstva

Info

Publication number
YU56302A
YU56302A YU56302A YUP56302A YU56302A YU 56302 A YU56302 A YU 56302A YU 56302 A YU56302 A YU 56302A YU P56302 A YUP56302 A YU P56302A YU 56302 A YU56302 A YU 56302A
Authority
YU
Yugoslavia
Prior art keywords
production
derivatives
indeno
thiazol
medicaments
Prior art date
Application number
YU56302A
Other languages
English (en)
Inventor
Gerhard Jaehne
Matthias Gossel
Martin Bickel
Original Assignee
Aventis Pharma Deutschland Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh. filed Critical Aventis Pharma Deutschland Gmbh.
Publication of YU56302A publication Critical patent/YU56302A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Fuses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)

Abstract

Pronalazak se odnosi na policiklične dihidrotiazole kao i na njihove fiziološki prihvatljive soli i fiziološki funkcionalne derivate. Opisuju se jedinjenja Formule I u kojoj ostaci imaju navedena značenja, kao i njihove fiziološki prihvatljive soli i postupak za njihovu proizvodnju. Ova jedinjenja su pogodna naprimer kao anorektična sredstva.[The invention relates to polycyclic dihydrothiazoles and to their physiologically compatible salts and physiologically functional derivatives. The invention relates to compounds of formula (I), wherein the groups have the given meanings, to their physiologically compatible salts and to a method for their production. The compounds are, for example, suitable for use as anorectic agents.
YU56302A 2000-02-23 2001-02-12 Derivati 8,8a-dihidro-indeno/1,2-d/taizola, koji su supstituisani u 8a-položaju,postupak za njihovu proizvodnju i njihova primena kod leka npr.kao anorektičnog sredstva YU56302A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10008275 2000-02-23

Publications (1)

Publication Number Publication Date
YU56302A true YU56302A (sh) 2005-11-28

Family

ID=7631989

Family Applications (1)

Application Number Title Priority Date Filing Date
YU56302A YU56302A (sh) 2000-02-23 2001-02-12 Derivati 8,8a-dihidro-indeno/1,2-d/taizola, koji su supstituisani u 8a-položaju,postupak za njihovu proizvodnju i njihova primena kod leka npr.kao anorektičnog sredstva

Country Status (27)

Country Link
US (1) US6403624B1 (sh)
EP (1) EP1259498B1 (sh)
JP (1) JP4898052B2 (sh)
KR (1) KR20020079891A (sh)
CN (1) CN1195747C (sh)
AT (1) ATE283265T1 (sh)
AU (1) AU781003B2 (sh)
BR (1) BR0108605A (sh)
CA (1) CA2400698A1 (sh)
CZ (1) CZ20022838A3 (sh)
DE (1) DE50104600D1 (sh)
EE (1) EE200200466A (sh)
ES (1) ES2231482T3 (sh)
HK (1) HK1055117A1 (sh)
HR (1) HRP20020688A2 (sh)
HU (1) HUP0300140A3 (sh)
IL (1) IL151327A0 (sh)
MX (1) MXPA02007021A (sh)
NO (1) NO20023978L (sh)
NZ (1) NZ520926A (sh)
PL (1) PL357547A1 (sh)
PT (1) PT1259498E (sh)
RU (1) RU2261860C2 (sh)
SK (1) SK12162002A3 (sh)
WO (1) WO2001062746A1 (sh)
YU (1) YU56302A (sh)
ZA (1) ZA200206487B (sh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10142660A1 (de) 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von Derivaten von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE10142659A1 (de) * 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von mehrfach substituierten Indan-1-ol. Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20080125403A1 (en) 2004-04-02 2008-05-29 Merck & Co., Inc. Method of Treating Men with Metabolic and Anthropometric Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CN102264228A (zh) 2008-10-22 2011-11-30 默沙东公司 用于抗糖尿病药的新的环状苯并咪唑衍生物
US8329914B2 (en) 2008-10-31 2012-12-11 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
WO2011106273A1 (en) 2010-02-25 2011-09-01 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2826649C (en) 2011-02-25 2016-07-26 Merck Sharp & Dohme Corp. Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
WO2012118972A2 (en) 2011-03-01 2012-09-07 Synegy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
US20140045746A1 (en) 2012-08-02 2014-02-13 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
BR112015019836A2 (pt) 2013-02-22 2017-07-18 Merck Sharp & Dohme composto, composição farmacêutica, e, uso de um composto
US9650375B2 (en) 2013-03-14 2017-05-16 Merck Sharp & Dohme Corp. Indole derivatives useful as anti-diabetic agents
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CN113388007A (zh) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
WO2015051496A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
US11072602B2 (en) 2016-12-06 2021-07-27 Merck Sharp & Dohme Corp. Antidiabetic heterocyclic compounds
EP3558298A4 (en) 2016-12-20 2020-08-05 Merck Sharp & Dohme Corp. ANTIDIABETIC SPIROCHROMAN COMPOUNDS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2640358A1 (de) 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
DE19844547C2 (de) * 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908539A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
RU2002125460A (ru) 2004-01-10
HUP0300140A2 (en) 2003-05-28
JP2003528825A (ja) 2003-09-30
SK12162002A3 (sk) 2003-02-04
ES2231482T3 (es) 2005-05-16
PL357547A1 (en) 2004-07-26
HRP20020688A2 (en) 2004-12-31
CZ20022838A3 (cs) 2002-11-13
RU2261860C2 (ru) 2005-10-10
ATE283265T1 (de) 2004-12-15
ZA200206487B (en) 2003-10-16
US6403624B1 (en) 2002-06-11
PT1259498E (pt) 2005-02-28
BR0108605A (pt) 2002-11-19
CA2400698A1 (en) 2001-08-30
JP4898052B2 (ja) 2012-03-14
KR20020079891A (ko) 2002-10-19
AU5615301A (en) 2001-09-03
NO20023978L (no) 2002-10-18
WO2001062746A1 (de) 2001-08-30
AU781003B2 (en) 2005-04-28
HK1055117A1 (en) 2003-12-24
EP1259498A1 (de) 2002-11-27
CN1195747C (zh) 2005-04-06
CN1423640A (zh) 2003-06-11
DE50104600D1 (de) 2004-12-30
NO20023978D0 (no) 2002-08-21
US20020058658A1 (en) 2002-05-16
EP1259498B1 (de) 2004-11-24
MXPA02007021A (es) 2003-03-27
HUP0300140A3 (en) 2004-10-28
IL151327A0 (en) 2003-04-10
NZ520926A (en) 2004-08-27
EE200200466A (et) 2003-12-15

Similar Documents

Publication Publication Date Title
YU56302A (sh) Derivati 8,8a-dihidro-indeno/1,2-d/taizola, koji su supstituisani u 8a-položaju,postupak za njihovu proizvodnju i njihova primena kod leka npr.kao anorektičnog sredstva
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
TNSN04199A1 (en) Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use
SE9904505D0 (sv) Novel compounds
MY137039A (en) Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
ME00376B (me) DIHIDROPTERIDINONI, POSTUPAK ZA NJlHOVO PRIPREMANJE I NJlHOVA PRIMJENA KAO LIJEK
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
YU56402A (sh) Derivati 8,8a-dihidro-indeno/1,2-d/tiazola,koji sadrže u 2 položaju supstituent sa sulfonamidnom ili sulfonskom strukturom; postupak za njihovu proizvodnju i njihova primena kao medikamenata
MXPA02009643A (es) Sintesis acortada de derivados de 3,3-diarilpropilamina.
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
HK1043117A1 (en) Polycyclic 2-amino-thiazole systems, method for the production thereof and medicament containing said compounds
RS88704A (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
HK1042300A1 (en) Polycyclic thiazole systems and their utilization as anorectics.
MY121362A (en) Benzoylguanidine derivatives with advantageous properties processes for preparing them and their use in the production of pharmaceutical compositions
YU57902A (sh) Supstituisani 8,8a-dihidro-3ah-indeno/1,2-d/tiazoli,postupak za njihovu proizvodnju i njihova primena u svojstvu lekova
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001851A (es) Inda-1-onas c2-disustituidas y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001846A (es) Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos.
CA2390631A1 (en) Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions
MXPA03003466A (es) Derivados de piranosido.
MXPA04001849A (es) Sistemas de indan-1-ol c2-disustituidos, metodo para su produccion y su uso como medicamentos.